The evaluation of the relationship of clinical and laboratory evidence with renal damage in the pediatric patients that had urinary tract infections
Abstract
Purpose: Urinary tract infection (UTI) is one of the important infectious diseases of childhood age. It causes serious late-term complications by leading to development of renal scarring in some pediatric patients. In the present study, it was aimed to determine the risk factors in development of renal damage in the pediatric patients that admitted with clinical of acute pyelonephritis.
Materials and methods: In our study, the medical files of the patients were admitted to the pediatric nephrology polyclinic of Pamukkale University Medical Faculty and followed-up with the diagnosis of urinary tract infection were retrospectively evaluated. The study included 197 patients diagnosed with acute pyelonephritis (confirmed by urine culture and clinical evidence) and undergoing dimercaptosuccinic acid (DMSA) scintigraphic imaging. The clinical evidence (fever, recurrent UTI, voiding dysfunction etc.), laboratory evidence (C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), white blood cell (WBC) count, polymorphonuclear leukocyte (PNL) count, mean platelet volume (MPV), platelet count, serum urea and creatinine levels) and imaging evidence
(urinary tract system ultrasonography (USG), voiding cystourethrography (VCUG) and DMSA scintigraphy) of the patients detected at admission and obtained by anamnesis were evaluated.
Results: The number of the female patients (n=153) was found significantly higher than number of the male patients (n=44) (p<0.001). It was detected that pretreatment fever of 38ºC and over, persisting clinical evidence for 2 days or longer, the presence of recurrent UTI and high levels of WBC, PNL, ESR and CRP significantly increased renal damage in the patients (p<0.001). It was determined that USG and VCUG have low sensitivity regarding prediction of renal damage.
Conclusion: Determination of renal damage rate by clinical and laboratory data detected at patient admission may contribute to a reduction in morbidity and mortality rates by applying an appropriate follow-up and treatment modality.
Keywords
Supporting Institution
Project Number
References
- 1. Tullus K, Shaikh N. Urinary tract infections in children. Lancet 2020;395:1659-1668. https://doi.org/10.1016/S0140-6736(20)30676-0.
- 2. Millner R, Becknell B. Urinary Tract Infections. Pediatr Clin North Am 2019;66:1-13. https://doi.org/10.1016/j.pcl.2018.08.002
- 3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;8;113. https://doi.org/10.1016/s0002-9343(02)01054-9 4. Moorthy I, Easty M, McHung K, Ridout D, Biassoni D, Gordon I. The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection. Arch Dis Child 2005;90:733-736. https://doi.org/10.1136/adc.2004.057604
- 5. Yüksel S, Yüksel G, Çakar N. Urinary tract infection in children. Turkiye Klinikleri J Pediatr 2002; 11: 41-49.
- 6. Sinha MD, Gibson P, Kane T, Lewis MA. Accuracy of ultrasonic detection of renal scarring in different centres using DMSA as the gold standart. Nephrol Dial Transplant 2007;22:2213-2216. https://doi.org/10.1093/ndt/gfm155
- 7. Benador D, Benador N, Slosman DO. Are younger children at highest risk of renal sequelae after pyelonephritis? Lancet 1997;349:17-19. https://doi.org/10.1016/s0022-3476(94)70248-9
- 8. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994;70:111-115 https://doi.org/10.1136/adc.70.2.111
- 9. Yüksel S, Çakar N, Çakmak FN, et al. Risk factors of renal damage in children with acut pyelonephritis. Turkiye Klinikleri J Pediatr 2007;16:158-164.
Details
Primary Language
English
Subjects
Paediatrics
Journal Section
Research Article
Authors
Selçuk Yüksel
0000-0001-9415-1640
Türkiye
Tülay Becerir
*
0000-0001-6277-1458
Türkiye
Burçin Seyhan
This is me
0000-0001-9177-7461
Türkiye
Publication Date
October 1, 2021
Submission Date
September 3, 2021
Acceptance Date
September 20, 2021
Published in Issue
Year 2021 Volume: 14 Number: 4
